AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Neuzumab 440mg Injection

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Trastuzumab (440mg)

Overview Neuzumab 440mg Injection

Herceptin-equivalent Neuzumab (440mg injection) treats breast and gastric cancers by targeting and eliminating HER2-positive cells. Administered intravenously by a healthcare professional, dosage and frequency are determined individually by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be immediately apparent, requiring several weeks or months; discontinue only under medical supervision. Common side effects include nausea, headache, rash, sleep disturbances, and increased infection risk. Neuzumab can lower blood cell counts, increasing vulnerability to infections, necessitating regular blood tests monitoring blood cell levels, cardiac function, liver health, and uric acid. Report any shortness of breath, cough, chills, or limb swelling to your doctor. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout the treatment period.

Uses of Neuzumab 440mg Injection

Cancers affecting the breast and stomach.

Major Benefits of Neuzumab 440mg Injection:

The medication will be administered by your physician or their designated nurse; self-medication is strongly discouraged.

Common Side effects of Neuzumab 440mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Neuzumab 440mg Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Neuzumab 440mg Injection works:

The injectable monoclonal antibody Neuzumab (440mg) is a genetically engineered IgG1 antibody targeting HER2, the human epidermal growth factor receptor 2. By binding to HER2 receptors, it prevents the excessive growth of breast and gastric cancer cells, thus leading to cancer cell death. This action also suppresses multiple downstream signaling cascades implicated in cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Neuzumab 440mg Injection and alcohol can lead to increased somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Neuzumab 440mg Injection during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in life-threatening circumstances where the potential benefits significantly outweigh the known hazards, as determined by a physician. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Neuzumab 440mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Neuzumab 440mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of 440mg Neuzumab injections in individuals with kidney disease appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary, however, physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Data on Neuzumab 440mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Neuzumab 440mg Injection :

Should you forget a scheduled dose of the Neuzumab 440mg injection, seek advice from your physician.

Facts to Know About Neuzumab 440mg Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Therapeutics
Behavioral Class Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Neuzumab 440mg Injection

Neuzumab 440mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bruising or bleeding. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea or vomiting, appetite loss, rapid heartbeat, discolored or decreased urine output, painful urination, and signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Women of childbearing age must use effective contraception throughout Neuzumab 440mg Injection therapy and for seven months afterward. Pregnancy planning can resume seven months post-treatment.
Treatment with Neuzumab 440mg Injection for early breast cancer should last one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Neuzumab 440mg Injection does not require fasting. Administration must be supervised by a physician experienced in cancer chemotherapy and performed only by a qualified healthcare professional.
Neuzumab 440mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous (SC) injection. Always verify the correct formulation is administered as prescribed. The IV formulation is for intravenous use only; it must not be given subcutaneously. Your doctor can decide if switching between IV and SC Neuzumab 440mg Injection is suitable for you.
Neuzumab 440mg Injection is a monoclonal antibody targeting the HER2 protein, abundant on some cancer cells. It inhibits cancer cell growth and spread by binding to HER2. Consequently, it's only effective in HER2-positive patients and is not indicated for those with HER2-negative cancer.
Using Neuzumab 440mg Injection with anthracyclines (like doxorubicin) can harm your heart. Your doctor must assess your heart health before and during treatment.
Cardiac evaluations should begin at treatment initiation, continue every three months during treatment, and then every six months post-treatment for up to two years following the final Neuzumab 440mg Injection dose. Patients with pre-existing cardiac conditions require evaluations every twelve weeks.
Neuzumab 440mg Injection
17,064
MRP 19,800
13% off